Laboratorio Reig Jofre Dividends and Buybacks
Dividend criteria checks 1/6
Laboratorio Reig Jofre is a dividend paying company with a current yield of 1.44% that is well covered by earnings.
Key information
1.4%
Dividend yield
0.003%
Buyback Yield
Total Shareholder Yield | 1.4% |
Future Dividend Yield | 1.4% |
Dividend Growth | 2.1% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | €0.040 |
Payout ratio | 34% |
Recent dividend and buyback updates
No updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, FEQ1 has been paying a dividend for less than 10 years.
Growing Dividend: FEQ1 has only been paying a dividend for 3 years, and since then payments have fallen.
Dividend Yield vs Market
Laboratorio Reig Jofre Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (FEQ1) | 1.4% |
Market Bottom 25% (DE) | 1.7% |
Market Top 25% (DE) | 4.9% |
Industry Average (Pharmaceuticals) | 1.4% |
Analyst forecast (FEQ1) (up to 3 years) | 1.4% |
Notable Dividend: FEQ1's dividend (1.44%) isn’t notable compared to the bottom 25% of dividend payers in the German market (1.73%).
High Dividend: FEQ1's dividend (1.44%) is low compared to the top 25% of dividend payers in the German market (4.81%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (34%), FEQ1's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: FEQ1 is paying a dividend but the company has no free cash flows.